Endometrial Cancer Immunology
Data from Uppsala University advance knowledge in endometrial cancer immunology
Published in Women's Health Weekly, July 19th, 2007
A new study, "Effects of 2-methoxyestradiol on endometrial carcinoma xenografts," is now available. "We have previously demonstrated that 2-methoxyestradiol (2-ME) inhibits the growth of human endometrial cancer HEC-1-A and RL-95-2 cells in vitro. In this study, we examined the effects of 2-ME on human endometrial carcinoma in severe combined immune deficient (SCID) mice," scientists in Uppsala, Sweden report.
"The potential side effects of 2-ME on SCID mice were also investigated. Severe combined immune deficient mice were injected with HEC-1-A cells (1 x 106/mouse) and a 18 day administration of 2-ME was followed after 1 week cell implantation. Tumor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Analysis confirms benefits of combining trastuzumab and chemotherapy - Breast Cancer
Link between immune system and mammary gland could shed new light on breast cancer - Breast Cancer
MRI Plus X-ray Mammography Doubles Breast Cancer Detection in Women at High Risk - Cancer
First baby is born after oocytes were matured in the lab and frozen - Cervical Cancer
New cervical cancer test increases the detection rate of abnormal cells - Endometriosis
Endometriosis increases the risk of certain cancers - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
